Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CLEC12B Decreases Melanoma Proliferation by Repressing Signal Transducer and Activator of Transcription 3.
Montaudié H, Sormani L, Dadone-Montaudié B, Heim M, Cardot-Leccia N, Tulic MK, Beranger G, Gay AS, Debayle D, Cheli Y, Raymond JH, Sohier P, Petit V, Rocchi S, Gesbert F, Larue L, Passeron T. Montaudié H, et al. Among authors: sohier p. J Invest Dermatol. 2022 Feb;142(2):425-434. doi: 10.1016/j.jid.2021.05.035. Epub 2021 Jul 24. J Invest Dermatol. 2022. PMID: 34310951 Free article.
BRN2 is a non-canonical melanoma tumor-suppressor.
Hamm M, Sohier P, Petit V, Raymond JH, Delmas V, Le Coz M, Gesbert F, Kenny C, Aktary Z, Pouteaux M, Rambow F, Sarasin A, Charoenchon N, Bellacosa A, Sanchez-Del-Campo L, Mosteo L, Lauss M, Meijer D, Steingrimsson E, Jönsson GB, Cornell RA, Davidson I, Goding CR, Larue L. Hamm M, et al. Among authors: sohier p. Nat Commun. 2021 Jun 17;12(1):3707. doi: 10.1038/s41467-021-23973-5. Nat Commun. 2021. PMID: 34140478 Free PMC article.
Second primary cutaneous melanoma in patients with advanced melanoma treated with anti-programmed-death-receptor-1 monoclonal antibodies.
Charvet E, Kramkimel N, Chaplain L, Gantzer A, Kassem O, Longvert C, Blom A, Dupin N, Aractingi S, Hamon M, Zimmermann U, Emile JF, Sohier P, Sidibé T, Saiag P, Funck-Brentano E. Charvet E, et al. Among authors: sohier p. Br J Dermatol. 2021 Apr;184(4):746-748. doi: 10.1111/bjd.19629. Epub 2020 Dec 1. Br J Dermatol. 2021. PMID: 33098566 No abstract available.
Recurrent FOXK1::GRHL and GPS2::GRHL fusions in trichogerminoma.
Kervarrec T, Pissaloux D, Poilane J, Tirode F, Tallet A, Collin C, Tallegas M, Berthon P, Gaboriaud P, Sohier P, Calonje E, Luzar B, Goto K, Cokelaere K, Lamant L, Balme B, Wild R, Neuville A, Deschamps L, Auberger E, Paumier V, Bonte H, Moulonguet I, Plantier F, Cales V, Pinsolle V, Roblet D, Dupuy F, Dallot A, Seris A, Jouary T, Houben R, Schrama D, Hesbacher S, Macagno N, Battistella M, Cribier B, Vergier B, de la Fouchardière A, Jullie ML. Kervarrec T, et al. Among authors: sohier p. J Pathol. 2022 May;257(1):96-108. doi: 10.1002/path.5872. Epub 2022 Mar 28. J Pathol. 2022. PMID: 35049062
Identification of potential common genetic modifiers of neurofibromas: a genome-wide association study in 1333 patients with neurofibromatosis type 1.
Pacot L, Sabbagh A, Sohier P, Hadjadj D, Ye M, Boland-Auge A, Bacq-Daian D, Laurendeau I, Briand-Suleau A, Deleuze JF, Margueron R, Vidaud M, Ferkal S, Parfait B, Vidaud D; NF-France Network; Pasmant E, Wolkenstein P. Pacot L, et al. Among authors: sohier p. Br J Dermatol. 2024 Jan 23;190(2):226-243. doi: 10.1093/bjd/ljad390. Br J Dermatol. 2024. PMID: 37831592
[A peculiar storiform tumor].
Sohier P, Guégan S. Sohier P, et al. Ann Pathol. 2021 Jun;41(3):330-332. doi: 10.1016/j.annpat.2021.02.003. Epub 2021 Apr 24. Ann Pathol. 2021. PMID: 33902964 French. No abstract available.
51 results